Published in

Taylor and Francis Group, OncoImmunology, 3(7), p. e1398874

DOI: 10.1080/2162402x.2017.1398874

Links

Tools

Export citation

Search in Google Scholar

Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment

Journal article published in 2017 by Chiara Riganti, Marcello Francesco Lingua, Iris Chiara Salaroglio, Chiara Falcomatà ORCID, Luisella Righi ORCID, Deborah Morena, Francesca Picca, Daniele Oddo ORCID, Joanna Kopecka, Monica Pradotto, Roberta Libener, Sara Orecchia, Paolo Bironzo ORCID, Valentina Comunanza ORCID, Federico Bussolino and other authors.
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO